More medicines will be spared from Medicare price negotiations, a change that is projected to wipe out billions in savings ...

Detailed price information for Unitedhealth Group Inc (UNH-N) from The Globe and Mail including charting and trades.

CVS Health’s first quarter results reflected steady execution across its core businesses, with management highlighting ...

Novo Nordisk has terminated its partnership with telehealth company Hims & Hers Health, accusing it of deceptively marketing weight-loss drugs.

Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. While Novo lost share to Eli Lilly's once-weekly Trulicity, Ozempic and Rybelsus ...

The FDA had resolved the shortage of Wegovy in April, and telehealth providers were advised to stop selling compounded ...

The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...

Pennsylvania Governor Josh Shapiro's office has said it is looking to change eligibility for weight loss drugs as part of its ...

Wegovy, which has been used for weight loss reasons, is not going to be covered by a Medicare Advantage plan or for Part D if it's prescribed for weight loss reasons.

Wegovy has gained attention as a powerful weight loss medication, especially for those struggling with obesity. However, if you're on Medicare or soon will be, you may be wo ...

WASHINGTON — Popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers ...